Model N Announces Regulatory Compliance Solutions Are Selected By Gilead Sciences (Foster City, CA)

SOUTH SAN FRANCISCO, Calif., Jan. 31 /PRNewswire/ -- Model N, Inc., the pioneer in revenue management for life sciences, announced that Gilead Sciences has selected the Model N Revenue Management suite for Regulatory Compliance, specifically applications for Government Pricing and Medicaid Claims Processing. The applications in the Model N Revenue Management suite for Regulatory Compliance are the first products in the industry designed to work seamlessly together to automate the end-to-end business processes from calculating government pricing through payment of governmental reimbursement claims for federal and state programs. As a result of this seamless integration, Model N customers benefit from a much faster, more efficient, and more accurate process for regulatory compliance that both improves visibility and lowers compliance risk.

"We are pleased to have been selected by Gilead Sciences and look forward to helping them enhance their operations infrastructure to enable their continued successful growth," said Zack Rinat, founder and CEO of Model N.

The Model N Regulatory Compliance Suite is the first and only solution to fully integrate Government Pricing with Medicaid Claims Processing on the same technology platform, enabling automated resubmissions to prior period Medicaid claims as a result of government pricing re-filings, providing analysts real- time alerts to all price changes. In addition, the Model N Regulatory Compliance Suite empowers pharmaceutical manufacturers to:

-- Satisfy rapidly evolving government mandates for calculating, reporting, and paying across multiple programs accurately and consistently; -- Minimize legal and business risks by automatically creating a transparent audit trail of processes and data; -- Consolidate pricing and contracting strategies by effectively managing the link between commercial and government pricing; -- More easily set up new Medicaid programs and process claims; -- Enable the definition of new formulas at the state level through Model N's unique Expression Builder; and -- Easily manage validations, approval routing, processing, and reporting for claims as well as import electronic claims through an easy-to-use wizard. About Model N

Model N is the pioneer in Revenue Management solutions, offering an integrated suite of applications for pricing, contracts, compliance, rebates, fees and chargebacks optimized for the industry practices of life sciences companies. Enabling the creation of a seamless, end-to-end process from pricing through settlements payment, Model N's uniquely integrated approach eliminates revenue leakage and delivers the visibility and controls needed to avoid the risks of non-compliance to government pricing and Sarbanes-Oxley regulations. Model N customers include Actelion Biopharmaceuticals; Boston Scientific Corporation; Bristol-Myers Squibb; Gilead Sciences; Ortho-Clinical Diagnostics, a Johnson & Johnson company; Pfizer, Inc.; Medtronic, Inc.; and Reliant Pharmaceuticals, Inc. Model N is located in South San Francisco, California. For additional information, visit www.modeln.com.

Model N is a mark of Model N, Inc. All other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

CONTACT: Carey Godbee of B3 Communications, +1-760-758-4406 orcgodbee@b3communications.com, for Model N, Inc.

Web site: http://www.modeln.com/